ATXIAVENUE THERAPEUTICS, INC.

Nasdaq avenuetx.com


$ 3.73 $ 0.10 (2.75 %)    

Friday, 17-May-2024 15:59:23 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 3.73
$ 3.94
$ 0.00 x 0
$ 0.00 x 0
$ 3.66 - $ 3.94
$ 3.52 - $ 93.75
38,431
na
3.51M
$ 0.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-18-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-13-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avenue-therapeutics-q1-eps-1540-misses-900-estimate

Avenue Therapeutics (NASDAQ:ATXI) reported quarterly losses of $(15.40) per share which missed the analyst consensus estimate o...

 avenue-therapeutics-may-offer-shares-of-common-stock-having-offering-price-of-up-to-39m-from-time-to-time-through-agent

- SEC Filing

 why-avenue-therapeutics-atxi-stock-is-falling-sharply

Avenue Therapeutics shares are trading lower by 20.7% during Monday's session. The company announced the exercise of warran...

 why-avenue-therapeutics-atxi-shares-are-getting-hammered

Avenue Therapeutics shares are trading lower by 28.5% during Wednesday's session. The company is implementing a 1-for-75 re...

 avenue-therapeutics-plans-to-effect-1-for-75-reverse-split-of-its-issued-and-outstanding-common-stock

Avenue expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement ...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION